Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Newsummit Launches $100 Million Fund for US Medical Device Makers

publication date: Sep 28, 2011
Newsummit Pharmaceutical Group teamed up with the Cleveland Bio Fund in a $100 million effort to help US biomedical device companies to commercialize their products in China. The funds were raised in China, where Newsummit is located. Cleveland Bio Fund will identify Cleveland-area medical device companies with US-approved products. These companies will be small-to-medium sized entities that have not been able to bring their products to China. Once all the candidates in the Cleveland area have been examined, the fund will widen its search to include companies from elsewhere in the US.

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital